APA (7th ed.) Citation

EJ, H., FJ, A., JM, M., E, A., SR, S., F, K., . . . S, A. (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet (London, England), 397(10287), 1819. https://doi.org/10.1016/S0140-6736(21)00947-8

Chicago Style (17th ed.) Citation

EJ, Haas, et al. "Impact and Effectiveness of MRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data." Lancet (London, England) 397, no. 10287 (2021): 1819. https://doi.org/10.1016/S0140-6736(21)00947-8.

MLA (9th ed.) Citation

EJ, Haas, et al. "Impact and Effectiveness of MRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data." Lancet (London, England), vol. 397, no. 10287, 2021, p. 1819, https://doi.org/10.1016/S0140-6736(21)00947-8.